A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled GDC-0214, a JAK1 Inhibitor, as Single- and Multiple-Ascending Doses in Healthy Volunteers

被引：0
|
作者：
Owen, Ryan [1 ]
Galanter, Joshua [2 ]
Zhu, Rui [2 ]
Cai, Fang [2 ]
Tom, Jennifer [2 ]
Wynne, Chris [3 ]
Durk, Matthew [2 ]
Chen, Liuxi [2 ]
Kenny, Jane [2 ]
She, Gao-hong [2 ]
Vadhavkar, Shweta [2 ]
Hwang, Olivia [2 ]
Chen, Hubert [2 ]
机构：
[1] Genentech Inc, San Francisco, CA USA
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] Christchurch Clin Studies Trust, Christchurch, New Zealand
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2020年 / 145卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
052
引用
收藏
页码：AB17 / AB17
页数：1
相关论文
共 50 条
  • [1] Phase I and scintigraphy studies to evaluate safety, tolerability, pharmacokinetics, and lung deposition of inhaled GDC-0214 in healthy volunteers
    Zhu, Rui
    Chen, Hubert
    Galanter, Joshua
    She, Gaohong
    Cai, Fang
    Durk, Matthew R.
    Zou, Yixuan
    Chen, Liuxi
    Kenny, Jane R.
    Vadhavkar, Shweta
    Warren, Simon
    Taylor, Glyn
    Hwang, Olivia
    Eliahu, Avi
    Wynne, Chris
    Owen, Ryan
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (05): : 1225 - 1237
  • [2] Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-Ascending Doses of Sunobinop in Healthy Participants
    Cipriano, Alessandra
    Kapil, Ram P.
    Zhou, Mingyan
    Shet, Manjunath S.
    Whiteside, Garth T.
    Willsie, Sandra K.
    Harris, Stephen C.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (07): : 790 - 800
  • [3] Safety, pharmacokinetics, and pharmacodynamics of TD-8236, an inhaled pan-JAK inhibitor, following single- and multiple-ascending doses in healthy volunteers and mild asthmatics
    Pfeifer, Nathan
    Guerin, Tadhg
    Colley, Kenneth
    Yates, Wayne
    Kaufman, Elad
    Woo, Jacky
    Graham, Richard
    Bourdet, David
    Singh, Dave
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [4] Single- and multiple-ascending dose studies to evaluate the safety, tolerability, and pharmacokinetics of daclatasvir and asunaprevir in healthy male Japanese subjects
    Shiozaki, Tomomi
    Ueno, Takayo
    Nagashima, Hirotaka
    Yamahira, Naomi
    Hiraoka, Masaki
    Eley, Tim
    Bifano, Marc
    Bertz, Richard J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (04) : 292 - 300
  • [5] Pharmacokinetics, safety and tolerability of single- and multiple-ascending doses of JNJ-64530440, a novel hepatitis B virus capsid assembly modulator, in healthy volunteers
    Kakuda, Thomas N.
    Yogaratnam, Jeysen Z.
    Westland, Christopher
    Gane, Edward J.
    Schwabe, Christian
    Vuong, Jennifer
    Patel, Megha
    Snoeys, Jan
    Talloen, Willem
    Lenz, Oliver
    Fry, John
    Chanda, Sushmita
    van Remoortere, Pieter
    ANTIVIRAL THERAPY, 2021, 26 (1-2) : 13 - 24
  • [6] A single-center, randomized, placebo-controlled, double-blind study to evaluate the safety, tolerability, and pharmacokinetics of multiple-ascending doses of pridopidine in healthy volunteers
    Osterberg, O.
    Ivkovic, J.
    Sundgreen, C.
    Muglia, P.
    Prang, A.
    Darpo, B.
    NEUROTHERAPEUTICS, 2013, 10 (01) : 175 - 175
  • [7] JNJ-64530440, a novel capsid assembly modulator: single- and multiple-ascending dose safety, tolerability and pharmacokinetics in healthy volunteers
    Kakuda, Thomas
    Yogaratnam, Jeysen
    Westland, Christopher
    Gane, Edward
    Schwabe, Christian
    Patel, Megha
    Talloen, Willem
    Lenz, Oliver
    van Remoortere, Pieter
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E469 - E469
  • [8] The first selective VAP-1 inhibitor in China, TT-01025-CL: safety, tolerability, pharmacokinetics, and pharmacodynamics of single- and multiple-ascending doses
    Yang, Yuanxun
    Yu, Lei
    Sheng, Zejuan
    Lin, Hui
    Weng, Zuyi
    Song, Wei
    Cao, Bei
    Zhao, Yu
    Gao, Yingsheng
    Ni, Shumao
    Wang, Huimin
    Ma, Tingting
    Huang, Lei
    Sun, Caixia
    Li, Juan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [9] PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE- AND MULTIPLE-ASCENDING DOSE STUDY OF THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE ASK1 INHIBITOR SRT-015 IN HEALTHY ADULTS
    Burge, Daniel J.
    Elias, Kathleen
    Plonowski, Artur
    Porter, Terence
    McDonnell, Neil
    HEPATOLOGY, 2022, 76 : S97 - S97
  • [10] A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of V-7404 in Healthy Adult Volunteers
    Kankam, Martin K.
    Burns, Jennifer M.
    Collett, Marc S.
    Corrado, Michael L.
    Hincks, Jeffrey R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (10)
12345